CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 252 filers reported holding CYTOKINETICS INC in Q2 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,955,064 | -72.9% | 134,252 | -70.0% | 0.11% | -69.5% |
| Q2 2023 | $14,600,712 | -7.3% | 447,600 | 0.0% | 0.35% | -7.7% |
| Q1 2023 | $15,751,044 | -22.4% | 447,600 | +1.0% | 0.38% | -23.0% |
| Q4 2022 | $20,298,260 | -5.4% | 443,000 | 0.0% | 0.49% | -11.9% |
| Q3 2022 | $21,463,000 | +36.6% | 443,000 | +10.8% | 0.55% | +21.2% |
| Q2 2022 | $15,716,000 | +251.5% | 400,000 | +93.7% | 0.46% | +304.4% |
| Q3 2020 | $4,471,000 | +145.0% | 206,495 | +166.7% | 0.11% | +126.0% |
| Q2 2020 | $1,825,000 | – | 77,417 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |